🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 hora
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/12/2011 | 42,35 | 42,35 | 41,20 | 41,92 | -0,83% | 2,72% | 1.149.000 |
| 06/12/2011 | 42,17 | 42,66 | 41,56 | 42,27 | +0,28% | 2,61% | 1.043.900 |
| 05/12/2011 | 42,24 | 42,60 | 41,69 | 42,15 | +1,15% | 2,15% | 1.498.800 |
| 02/12/2011 | 41,83 | 42,20 | 41,60 | 41,67 | +0,31% | 1,43% | 937.400 |
| 01/12/2011 | 40,69 | 41,66 | 40,27 | 41,54 | +1,54% | 3,42% | 656.800 |
| 30/11/2011 | 39,95 | 40,91 | 39,70 | 40,91 | +4,58% | 3,03% | 1.090.800 |
| 29/11/2011 | 39,73 | 39,83 | 38,93 | 39,12 | -1,54% | 2,27% | 573.600 |
| 28/11/2011 | 39,92 | 40,03 | 39,34 | 39,73 | +1,02% | 1,73% | 675.600 |
| 25/11/2011 | 39,62 | 39,98 | 39,25 | 39,33 | -0,73% | 1,84% | 146.700 |
| 23/11/2011 | 40,48 | 40,54 | 39,37 | 39,62 | -2,68% | 2,89% | 601.900 |
| 22/11/2011 | 40,52 | 40,88 | 39,83 | 40,71 | +0,32% | 2,59% | 497.300 |
| 21/11/2011 | 40,67 | 40,97 | 40,39 | 40,58 | -1,02% | 1,43% | 665.100 |
| 18/11/2011 | 40,99 | 41,73 | 40,01 | 41,00 | +0,10% | 4,20% | 1.147.000 |
| 17/11/2011 | 41,58 | 41,84 | 40,45 | 40,96 | -1,68% | 3,34% | 745.000 |
| 16/11/2011 | 41,96 | 42,38 | 41,55 | 41,66 | -1,12% | 1,98% | 495.500 |
| 15/11/2011 | 42,19 | 42,37 | 41,56 | 42,13 | -0,45% | 1,92% | 441.900 |
| 14/11/2011 | 41,68 | 42,35 | 41,45 | 42,32 | +1,54% | 2,16% | 495.600 |
| 11/11/2011 | 42,44 | 42,60 | 41,47 | 41,68 | -0,81% | 2,66% | 986.500 |
| 10/11/2011 | 41,81 | 43,60 | 41,32 | 42,02 | -1,25% | 5,45% | 1.153.900 |
| 09/11/2011 | 42,30 | 43,17 | 42,15 | 42,55 | -1,64% | 2,41% | 1.265.800 |
| 08/11/2011 | 42,61 | 43,75 | 41,96 | 43,26 | +1,88% | 4,20% | 1.322.400 |
| 07/11/2011 | 42,44 | 43,27 | 41,26 | 42,46 | +0,45% | 4,74% | 929.900 |
| 04/11/2011 | 42,37 | 42,80 | 41,65 | 42,27 | +0,59% | 2,71% | 836.800 |
| 03/11/2011 | 41,50 | 42,28 | 40,59 | 42,02 | +2,29% | 4,07% | 1.369.200 |
| 02/11/2011 | 42,28 | 42,50 | 40,50 | 41,08 | -1,65% | 4,73% | 1.015.700 |
| 01/11/2011 | 43,11 | 43,15 | 41,67 | 41,77 | -4,48% | 3,43% | 1.303.400 |
| 31/10/2011 | 44,40 | 44,80 | 42,97 | 43,73 | -2,37% | 4,12% | 1.497.700 |
| 28/10/2011 | 43,62 | 44,94 | 43,46 | 44,79 | +2,45% | 3,39% | 1.308.500 |
| 27/10/2011 | 43,16 | 43,97 | 41,78 | 43,72 | +5,40% | 5,07% | 2.497.100 |
| 26/10/2011 | 41,79 | 42,24 | 41,04 | 41,48 | +0,27% | 2,87% | 1.273.800 |